Erectile dysfunction
Most common male sexual dysfunction, treatable with lifestyle and medication.
Erectile dysfunction (ED), also referred to as impotence, is a form of sexual dysfunction in males characterized by the persistent or recurring inability to achieve or maintain a penile erection with sufficient rigidity and duration for satisfactory sexual activity. It is the most common sexual problem in males and can cause psychological distress due to its impact on self-image and sexual relationships. The term erectile dysfunction does not encompass other erection-related disorders, such as priapism.
- prevalence_50_59
- 18%
- prevalence_70_75
- 37%
- untreated_cases
- 75%
- psychosocial_cases
- 10%
- common_treatment_class
- PDE5 inhibitors
- diagnostic_code_DSM5
- F52.21
- diagnostic_code_ICD10
- F52.2
Lore & Background
The majority of ED cases are attributed to physical risk factors and predictive factors, which can be categorized as vascular, neurological, local penile, hormonal, and drug-induced. Notable predictors include aging, cardiovascular disease, diabetes mellitus, high blood pressure, obesity, abnormal lipid levels, hypogonadism, smoking, depression, and medication use. Approximately 10% of cases are linked to psychosocial factors such as depression, stress, and relationship problems. ED is reported in 18% of males aged 50 to 59 years and 37% in males aged 70 to 75. Treatment encompasses addressing underlying causes, lifestyle modification, and psychosocial issues. Medication-based therapies, specifically PDE5 inhibitors such as sildenafil, are commonly used; these drugs dilate blood vessels to increase blood flow into the spongy tissue of the penis. Less frequently employed treatments include prostaglandin pellets inserted into the urethra, injection of smooth-muscle relaxants and vasodilators directly into the penis, penile implants, penis pumps, and vascular surgery. Causes include diets high in saturated fat, prescription drugs (e.g., SSRIs, beta blockers, antihistamines), neurogenic disorders (e.g., diabetic neuropathy, multiple sclerosis), cavernosal disorders (e.g., Peyronie's disease), hyperprolactinemia, psychological causes, surgery (e.g., radical prostatectomy), aging, kidney disease, lifestyle habits such as smoking, and preliminary research indicates COVID-19 viral infection may affect sexual and reproductive health.
Reader's Guide
Erectile dysfunction is significant as the most common sexual problem in males, affecting a substantial portion of the aging population—18% of males aged 50–59 and 37% of those aged 70–75. Its impact extends beyond physical function to psychological distress, affecting self-image and sexual relationships, yet about 75% of diagnosed cases go untreated, often due to embarrassment. The condition is primarily driven by physical factors such as cardiovascular disease, diabetes, and smoking, with only about 10% of cases linked to psychosocial causes. Treatment has advanced with PDE5 inhibitors like sildenafil, which facilitate erections by dilating blood vessels, though other options exist for refractory cases. The diagnostic process distinguishes physiological from psychological ED, often using the presence of nocturnal erections as a key indicator. The condition is formally recognized in the DSM-5-TR as Erectile Disorder (F52.21) and in the ICD-10 under Failure of genital response (F52.2). Ongoing research explores links to COVID-19 and the complex relationship with pornography, while rare iatrogenic disorders such as post-SSRI sexual dysfunction remain poorly understood.
Did You Know?
- About 75% of diagnosed cases of ED go untreated.
- ED is reported in 18% of males aged 50 to 59 years and 37% in males aged 70 to 75.
- Approximately 10% of ED cases are linked to psychosocial factors such as depression, stress, and relationship problems.
- PDE5 inhibitors such as sildenafil function by dilating blood vessels, facilitating increased blood flow into the spongy tissue of the penis.
Frequently Asked Questions
Who is Erectile dysfunction?
ED, also called impotence, is the most prevalent male sexual dysfunction, defined as a persistent or recurring inability to achieve or maintain an erection rigid and lasting enough for satisfactory intercourse. It is catalogued under DSM-5 code F52.21 and is explicitly distinct from other erection-related conditions such as priapism.
What are Erectile dysfunction's powers/role?
Its primary 'ability' is disrupting the vascular and neurological processes needed for penile rigidity, affecting roughly 18% of men aged 50–59 and climbing to about 37% by age 70–75. Around 10% of cases stem from psychosocial factors such as stress or relationship strain rather than purely physical causes.
How does Erectile dysfunction's story end?
The condition is highly treatable; first-line pharmacotherapy typically involves PDE5 inhibitors, and lifestyle modifications can further improve outcomes. Because an estimated 75% of affected men never seek treatment, early diagnosis and open conversation with a clinician are key to resolving the issue.
Why is Erectile dysfunction important?
As the single most common sexual complaint in males, it carries significant weight because it frequently erodes self-image and strains intimate relationships, producing measurable psychological distress. Its high prevalence across middle-aged and older populations makes it a major public-health and quality-of-life concern.
What's Erectile dysfunction's backstory / origin?
ED can arise from a mix of vascular, hormonal, neurological, and psychological contributors, with cardiovascular disease and diabetes being frequent upstream drivers. The interplay of aging, comorbid illness, and psychosocial stress means no single 'villain' is usually to blame.
More in Common Diseases & Disorders 25-34
Elsewhere in the Common Diseases & Disorders universe
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record